Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (61-70 of 333) with videos related to

Pageof 34
Sort By:
Neuroepidemiology|November 13, 2008
Smoking status over two years in patients with multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2012
EDSS variability before randomization may limit treatment discovery in primary progressive MSJiameng Zhang, Emmanuelle Waubant, Gary Cutter, et al.
Neuroepidemiology|February 2, 2011
Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseasesRuth Ann Marrie, Ralph I Horwitz, Gary Cutter, et al.
Neurology|June 20, 2020
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialAmber Salter, Kaarina Kowalec, Kathryn C Fitzgerald, et al.
Contemporary Clinical Trials|December 30, 2014
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMSXiangyi Meng, Peter S Chin, Ron Hashmonay, et al.
Muscle & Nerve|May 15, 2012
Psychometric evaluation of the myasthenia gravis composite using Rasch analysisReza Sadjadi, Mark Conaway, Gary Cutter, et al.
Journal of Biopharmaceutical Statistics|December 19, 2025
The proportional treatment effect: A metric that empowers and connectsGuoqiao Wang, Yijie Liao, Caiyan Li, et al.
Statistics in Medicine|September 23, 2025
Response to Letter to the Editor "Comments on 'Novel Non-Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods'"Guoqiao Wang, Guogen Shan, Yan Li, et al.
International Journal of MS Care|June 3, 2016
Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital DatabaseFrank R Ernst, Jennifer Pocoski, Gary Cutter, et al.
Advances in Therapy|November 22, 2014
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosisRichard Nixon, Niklas Bergvall, Davorka Tomic, et al.
Pageof 34

Showing results (61-70 of 333) with videos related to

Sort By:
Pageof 34
Neuroepidemiology|November 13, 2008
Smoking status over two years in patients with multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2012
EDSS variability before randomization may limit treatment discovery in primary progressive MSJiameng Zhang, Emmanuelle Waubant, Gary Cutter, et al.
Neuroepidemiology|February 2, 2011
Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseasesRuth Ann Marrie, Ralph I Horwitz, Gary Cutter, et al.
Neurology|June 20, 2020
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialAmber Salter, Kaarina Kowalec, Kathryn C Fitzgerald, et al.
Contemporary Clinical Trials|December 30, 2014
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMSXiangyi Meng, Peter S Chin, Ron Hashmonay, et al.
Muscle & Nerve|May 15, 2012
Psychometric evaluation of the myasthenia gravis composite using Rasch analysisReza Sadjadi, Mark Conaway, Gary Cutter, et al.
Journal of Biopharmaceutical Statistics|December 19, 2025
The proportional treatment effect: A metric that empowers and connectsGuoqiao Wang, Yijie Liao, Caiyan Li, et al.
Statistics in Medicine|September 23, 2025
Response to Letter to the Editor "Comments on 'Novel Non-Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods'"Guoqiao Wang, Guogen Shan, Yan Li, et al.
International Journal of MS Care|June 3, 2016
Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital DatabaseFrank R Ernst, Jennifer Pocoski, Gary Cutter, et al.
Advances in Therapy|November 22, 2014
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosisRichard Nixon, Niklas Bergvall, Davorka Tomic, et al.
Pageof 34